PGCM
MED icon

Prescott Group Capital Management’s Medifast MED Stock Holding History

Prescott Group Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-111,244
Closed -$1.19M – 281
2025
Q4 		$1.19M Buy
111,244
+31,275
+39% +$374K 0.11% 182
2025
Q3 		$1.09M Hold
79,969
– – 0.12% 160
2025
Q2 		$1.12M Sell
79,969
-30,031
-27% -$395K 0.13% 155
2025
Q1 		$1.48M Hold
110,000
– – 0.22% 130
2024
Q4 		$1.94M Buy
+110,000
New +$2.04M 0.26% 120

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Prescott Group Capital Management's MED Position: Q1 2026 in Review

Prescott Group Capital Management sold out of Medifast (MED) in Q1 2026, closing a stake of 111,244 shares — an estimated $1.19M sold.

Prescott Group Capital Management first reported a position in MED in Q4 2024 and held it in 5 quarters. The position peaked at $1.94M in Q4 2024. 112 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Prescott Group Capital Management reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
  • Prescott Group Capital Management sold 111,244 Medifast shares in Q1 2026, an estimated $1.19M.
  • Prescott Group Capital Management first reported a position in Medifast in Q4 2024 and held it in 5 quarters.
  • Prescott Group Capital Management's Medifast position peaked at $1.94M in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Prescott Group Capital Management's 13F filing for Q1 2026, filed 7 May 2026.